The global blood culture tests market in terms of revenue was estimated to be worth $5.2 billion in 2023 and is poised to reach $7.6 billion by 2028, growing at a CAGR of 8.0% from 2023 to 2028. Growth in this market is primarily fueled by growing demand for rapid diagnostic techniques, high prevalence of infectious diseases , growing incidence of sepsis cases and high cost treatment, rising...